Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Timofte

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Transplantation Proceedings|September 18, 2022
A Case Report of Breakthrough Infections With 2 SARS-CoV-2 Variants in a Lung Transplant PatientLuke D Mahan, Manish R Mohanka, John Joerns, et al.
Transplantation|March 7, 2022
High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant PatientsJohn Joerns, Srinivas Bollineni, Luke D Mahan, et al.
Viruses|October 28, 2023
Crossroads between Autoimmunity and COVID-19 in Lung Transplant RecipientsMadhusudhanan Narasimhan, Alagarraju Muthukumar, Kavithalakshmi Sataranatarajan, et al.
Clinical Transplantation|December 10, 2025
Belatacept-Based Immunosuppression and Donor-Specific Antibodies in Lung Transplant: A Multi-Institutional Retrospective StudyMoustafa Younis, Christopher I Mederos, Cecelia M Miller, et al.
Transplant Immunology|December 1, 2025
Conversion to belatacept-based immunosuppression as a calcineurin sparing regimen in lung transplant: A multi-institutional retrospective studyMoustafa Younis, Cecelia M Miller, Christopher I Mederos, et al.
Transplantation Proceedings|July 31, 2022
COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough InfectionsSrinivas Bollineni, Luke D Mahan, Adrian Lawrence, et al.
ERJ Open Research|May 5, 2020
Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPDIrina Timofte, Marniker Wijesinha, Roumen Vesselinov, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 5, 2021
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)Michael Keller, Errol Bush, Joshua M Diamond, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 18, 2020
Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft lossKieran Halloran, Michael D Parkes, Irina Timofte, et al.
Clinical Transplantation|October 4, 2024
Anti-Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single-Center ExperienceColin T Dunn, William Brandon, Alan Jacob, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Transplantation Proceedings|September 18, 2022
A Case Report of Breakthrough Infections With 2 SARS-CoV-2 Variants in a Lung Transplant PatientLuke D Mahan, Manish R Mohanka, John Joerns, et al.
Transplantation|March 7, 2022
High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant PatientsJohn Joerns, Srinivas Bollineni, Luke D Mahan, et al.
Viruses|October 28, 2023
Crossroads between Autoimmunity and COVID-19 in Lung Transplant RecipientsMadhusudhanan Narasimhan, Alagarraju Muthukumar, Kavithalakshmi Sataranatarajan, et al.
Clinical Transplantation|December 10, 2025
Belatacept-Based Immunosuppression and Donor-Specific Antibodies in Lung Transplant: A Multi-Institutional Retrospective StudyMoustafa Younis, Christopher I Mederos, Cecelia M Miller, et al.
Transplant Immunology|December 1, 2025
Conversion to belatacept-based immunosuppression as a calcineurin sparing regimen in lung transplant: A multi-institutional retrospective studyMoustafa Younis, Cecelia M Miller, Christopher I Mederos, et al.
Transplantation Proceedings|July 31, 2022
COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough InfectionsSrinivas Bollineni, Luke D Mahan, Adrian Lawrence, et al.
ERJ Open Research|May 5, 2020
Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPDIrina Timofte, Marniker Wijesinha, Roumen Vesselinov, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 5, 2021
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)Michael Keller, Errol Bush, Joshua M Diamond, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 18, 2020
Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft lossKieran Halloran, Michael D Parkes, Irina Timofte, et al.
Clinical Transplantation|October 4, 2024
Anti-Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single-Center ExperienceColin T Dunn, William Brandon, Alan Jacob, et al.
Pageof 4